摘要
目的建立改良单叠氮丙啶(propidium monoazide xx,PMAxx)-荧光定量PCR(qPCR)鉴定MTB活菌和热灭活菌的方法,并探讨PMAxx-qPCR进行抗结核药物体外活性检测的价值。方法通过活菌和热灭活菌优化PMAxx针对MTB菌株H37Rv的预处理条件,包括曝光时间、暗孵育时间、PMAxx浓度,以及靶标DNA片段长度等。通过绘制量效曲线和建立循环阈值(Cq)与菌负荷的标准曲线,应用PMAxx-qPCR法计算测定异烟肼(INH)、利福平(RFP)的体外抗菌活性,评价检测敏感度,并分别与微孔板Alamar Blue(MABA)法和菌落形成单位(CFU)计数法进行比较,菌落计数采用独立样本t检验进行统计分析,以P<0.05为差异有统计学意义。结果当细菌负荷设定为107 CFU/ml时,在PMAxx浓度为10μmol/L、暗孵育10 min后曝光15 min可有效鉴别活菌、死菌(△Cq死-活=6.772±0.453),且使用>200 bp靶标片段可更有效地反映活菌、死菌的差异。PMAxx-qPCR方法在药物作用后3d可获得与MABA法一致性良好的最低抑菌浓度(MIC)检测结果(INH:0.049~0.076μg/ml与0.032~0.064μg/ml,t=0.782,P=0.491;RFP:0.102~0.145μg/ml与0.051~0.079μg/ml,t=2.828,P=0.066)。定量标准曲线Cq与菌计数(lgCFU/ml)呈良好的线性关系(R2=0.9863),最低检测限为102 CFU/ml,且PMAxx-qPCR方法和CFU计数方法测算16×MIC、8×MIC、4×MIC、2×MIC和1×MIC浓度的INH的抗菌计数分别为(4.376±0.344)和(4.325±0.318)、(4.232±0.106)和(3.936±0.194)、(4.122±0.277)和(3.874±0.105)、(3.950±0.113)和(3.675±0.250)、(3.770±0.228)和(3.618±0.257)CFU/ml,两种方法计数比较差异均无统计学意义(t值分别为0.165、1.894、1.186、1.419和0.626,P值分别为0.880、0.199、0.357、0.292和0.595),而16×MIC、8×MIC、4×MIC、2×MIC和1×MIC浓度的RFP的抗菌计数分别为(4.577±0.216)和(4.675±0.250)、(4.445±0.054)和(4.374±0.675)、(3.627±0.173)和(3.154±0.076)、(1.946±0.359)和(2.159±0.083)、(1.552±0.423)和(0.960±0.202)CFU/ml,两种方法计数比较差异均无统计学意义(t值分别为0.469、0.199、3.535、0.784、1.777,P值分别为0.671、0.855、0.071、0.490、0.174)。结论建立的PMAxx-qPCR方法稳定,可应用于一线抗结核药物INH和RFP的活性检测,敏感度高且快速准确。
Objective To establish the method of modified propidium monoazide(PMAxx)-quantitative PCR(qPCR) for identifying live and heat-inactivated Mycobacterium tuberculosis(MTB),and evaluate the value of PMAxx-qPCR assay to detect activity of antituberculosis drugs in vitro.Methods The pre-treatment conditions of PMAxx including light-exposure time,dark-incubation time,PMAxx concentration and DNA amplification size were optimized with live and heat-inactivated MTB(H37 Rv).Through plotting the dose-effect curve and establishing the standard curve of the quantification cycle(Cq) value and bacterial load, the antibacterial activity of isoniazid(INH) and rifampin(RFP) in vitro were calculated by this assay, the detection sensitivity was evaluated,and comparing it to Microplate Alamar Blue assay(MABA) and colony forming unit(CFU) method,the colony count was analyzed by independent sample t-test,and the difference was statistically significant(P<0.05).Results When the bacterial load was set as 107 CFU/ml,the dead and living bacteria could be identified effectively(△Cqdead-live=6.772±0.453) under the condition of the concentration of PMAxx with 10 μmol/L,dark incubation for 10 min and light-exposure for 15 min. The difference of the dead and living bacteria could be confirmed more effectively by using the > 200 bp target DNA fragments.PMAxx-qPCR method obtained good MIC results comparing to MABA method in three days(INH:0.049-0.076 μg/ml vs.0.032-0.064 μg/ml,t=0.782,P=0.491;RFP:0.102-0.145 μg/ml vs.0.051-0.079 μg/ml,t=2.828,P=0.066).The Cq value of the quantitative standard curve showed a good linear relationship with the CFU(IgCFU/ml)(R2=0.9863),and the limit number of detection was 102 CFU/ml.Meanwhile,the antibacterial counts of 16 X, 8×,4×,2× and 1×MIC concentrations of INH by the PMAxx-qPCR method and CFU method were(4.376 ± 0.344) and(4.325 ±0.318) CFU/ml,(4.232±0.106) and(3.936±0.194) CFU/ml,(4.122±0.277) and(3.874±0.105) CFU/ml,(3.950±0.113) and(3.675±0.250) CFU/ml,(3.770±0.228) and(3.618±0.257) CFU/ml,respectively.The antibacterial counts of 16 X,8×,4×, 2 X and 1×MIC concentrations of RFP by the PMAxx-qPCR method and CFU method were(4.577±0.216) and(4.675±0.250) CFU/ml,(4.445±0.054) and(4.374±0.675) CFU/ml,(3.627±0.173) and(3.154±0.076) CFU/ml,(1.946±0.359) and(2.159±0.083) CFU/ml,(1.552±0.423)and(0.960±0.202) CFU/ml respectively,all differences were not statistically significant((t=0.165,P=0.880;t=1.894,P=0.199;t=1.186,P=0.357;t=1.419,P=0.292;t=0.626,P=0.595) and(t=0.469,P=0.671;t=0.199,P=0.855;t=3.535,P=0.071;t=0.784,P=0.490;t=1.777,P=0.174)).Conclusion The established PMAxx-qPCR method in this study is stable.It can be used to detect the activity of the first-line antituberculous drugs including INH and RFP with high sensitivity,rapid and accuracy.
作者
张静
陈曦
王彬
付雷
陆宇
陈效友
ZHANG Jing;CHEN Xi;WANG Bin;FU Lei;LU Yu;CHEN Xiao-you(Beijing Key Laboratory of Drug-Resistant Tuberculosis Research,Department of Pharmacology,Beijing Tuberculosis and Thoracic Tumor Research Institute,Beijing Chest Hospital,Capital Medical University,Beijing 101149,China)
出处
《中国防痨杂志》
CAS
CSCD
2020年第5期472-480,共9页
Chinese Journal of Antituberculosis
基金
“十二五”国家重大科技专项(2015ZX10003001-003)。
关键词
单叠氮丙啶
抗结核药
聚合酶链反应
微生物敏感性试验
对比研究
Propidium monoazide(PMA)
Antitubercular agents
Polymerase chain reaction
Microbial sensitivity tests
Comparative study
